White Papers
Access in-depth white papers detailing the latest advancements in anti-aging science.
Quick Links
White Papers
Cibinetide: Unlocking the Potential of Peptide Therapy for Inflammation, Neuropathy, and Tissue Repair
This white paper delves into the current body of research surrounding cibinetide, examining its efficacy, safety, and areas where further exploration is needed.
Copper Tripeptide Medical Evidence
Copper tripeptide has been suggested as an anti-aging therapeutic agent. We review the evidence that supports the use of the peptide in the human body, while also considering current knowledge and experiments on other models. The whitepaper considers the specific pathways that allow copper tripeptide to provide these effects.
Estrogen Vaginal Cream Medical Evidence
This white paper reviews the current evidence related to the use of estrogen vaginal cream, with a focus on its efficacy in specific scenarios, as well as the safety profile that it offers. We also consider usage cases where it seems to be the superior choice compared to an oral route of estrogen administration.
Female Testosterone Replacement Therapy Medical Evidence
Testosterone replacement therapy for women is often overlooked, particularly when addressing issues such as increased fat distribution or decreased sex drive. However, emerging research suggests that this therapy could be a viable option for some patients.
FG Loop Medical Evidence
FG Loop is a peptide that has been suggested to improve synapse formation, enhance the overall health of neurons, improve the body’s response to stress, and hold the potential to provide an antidepressant effect. This white paper focuses on the evidence that has been presented to date regarding the use of FG Loop as a therapeutic peptide in these cases. We will consider multiple studies to identify specific pathways that the peptide focuses on in order to provide the expected benefits.
FGL (I): Clinical Insights and Medical Evidence
This white paper consolidates current evidence on the clinical implications of FGL-1, emphasizing its diagnostic and therapeutic potential across multiple medical disciplines.
Glutathione Medical Evidence
This white paper aims to provide a comprehensive review of the therapeutic applications of glutathione, focusing on its mechanisms of action, clinical benefits, and limitations.
Human Chorionic Gonadotropin (hCG):
This white paper consolidates current evidence on the diverse applications of hCG, addressing its therapeutic potential, limitations, and the necessity for further exploration.
Hexarelin: A Multifaceted Peptide for Anti-Aging and Therapeutic Advancement
This white paper consolidates the existing body of evidence on hexarelin, elucidating its potential role in managing age-related and chronic conditions.
IGF-1 LR3: A Comprehensive Review of Medical Evidence
This white paper consolidates existing findings to underscore the clinical implications of IGF-1 LR3.
Male Testosterone Replacement Therapy Medical Evidence
When testosterone levels in men decline, it may lead to various adverse effects. While this decline is a natural part of aging, some men experience it more rapidly. In cases where hormone levels drop significantly, testosterone replacement therapy (TRT) is often recommended as a treatment.
Methenolone and Aging
This white paper delves into the available evidence surrounding methenolone, providing a detailed analysis of its clinical applications, mechanisms of action, and potential side effects.
Methylene Blue Medical Evidence
This white paper explores the broad applications, safety considerations, and therapeutic potential of methylene blue, summarizing current evidence to illuminate its diverse uses and underscore the importance of advancing research in this field.
NAD+ Medical Evidence
NAD+ has been recognized as a critical component in metabolism, energy homeostasis, and disease prevention. Studies have already shown that treatment with NAD+ may offer regenerative properties while benefiting the mitochondria as well. This whitepaper considers current research regarding the use of NAD+ to provide a comprehensive overview of how it can be used, outlining the role it plays in various bodily functions and processes.
Pentadeca Arginate Medical Evidence
This white paper delves into the scientific landscape of pentadeca arginate, synthesizing existing research while identifying areas in need of further exploration.
PT-141 Medical Evidence
PT-141, also called Bremelanotide, has been studied extensively for its potential in sexual dysfunctions. Research has focused on the use of PT-141 in both men and women, with positive results shown for a low libido, as well as erectile difficulties in male patients. The purpose of this white paper is to provide an overview of current evidence and to explore the potential of using this therapeutic agent as an alternative to current treatments.
Rapamycin Medical Evidence
The purpose of this white paper is to offer an overview of what’s currently known about Rapamycin in cancer treatment and disease risk reduction.
Retatrutide Medical Evidence
This white paper critically evaluates the therapeutic potential of retatrutide, with a focus on its efficacy, safety profile, and comparative advantages over existing treatments.
Selank Medical Evidence
Selank has been proposed as a promising peptide for enhancing neurological health and providing nootropic benefits, aimed at improving cognitive functions such as concentration and memory. Additionally, there is growing interest in its potential as a treatment for alleviating anxiety symptoms. This white paper reviews the existing evidence and evaluates the overall efficacy that patients may experience with Selank, based on current research.
Sermorelin Medical Evidence
The aim of this white paper is to provide a comprehensive overview of current evidence surrounding Sermorelin.
SS-31 Medical Evidence
SS-31 is a type of peptide that has been found to target the mitochondria specifically, providing antioxidant activities and may also be useful in reducing inflammation throughout the body. This makes SS-31 an interesting research target when considering ways to counteract chronic inflammation, which has been associated with several diseases.
Synapsin Medical Evidence
Synapsins have shown potential in helping to improve neuron health and reducing the rate at which neurons are damaged. This makes it a potential therapeutic agent in cases of Alzheimer’s disease and poor cognition. There are also other areas that studies have focused on to provide more evidence on the use of synapsins in various neurological conditions.
Synergistic Potential of Semaglutide and Cagrilinitide in Weight Loss Therapy
This white paper consolidates insights from a wide range of evidence examining the combination of semaglutide and cagrilintide for weight management and metabolic health.
TB-500 Medical Evidence
This white paper focuses on specific scientific evidence that has been previously published, surrounding the use of TB-500 in various settings.
Tesamorelin Medical Evidence
Tesamorelin is a synthetic peptide, typically administered via injection, that stimulates the release of growth hormones in the body. It has been proposed as a therapeutic agent to reduce abdominal fat accumulation. While research on Tesamorelin is primarily focused on its use in patients with HIV, this white paper aims to examine the existing evidence on its efficacy in reducing visceral fat and to evaluate its overall safety profile.
Tesofensine Medical Evidence
Tesofensine has demonstrated potential as a treatment for obesity, with the added benefit of regulating blood glucose levels. This white paper aims to analyze the current evidence regarding Tesofensine’s effectiveness both as an anti-obesity therapy and in glucose control. By reviewing previous clinical trials and medical research, we assess the peptide’s mechanisms of action and its potential role in addressing both obesity and metabolic disorders.
Thymosin Alpha-1 Medical Evidence
Thymosin Alpha-1 has shown potential as an immune modulator. The effects of the peptide go beyond strengthening the immune system, as it was also found that it reduces inflammation, supports patients with cancer, and may possess anti-viral properties.
Thymulin Medical Evidence
This white paper delves into current evidence, exploring the potential benefits of Thymulin as a synthetic therapeutic agent across various medical conditions. The objective is to present findings from scientific studies and clinical trials that have demonstrated its potential and provided insight into the safety profile of this peptide.
Tirzepatide Medical Evidence
Tirzepatide has shown potential as an alternative therapeutic agent to GLP-1 analogs, which means it helps to lower glucose levels and can play a role in anti-obesity treatments. The peptide has also shown potential for improving cognition and provides benefits for the cardiovascular system.